Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
28.6M
-
Shares change
-
-1.69M
-
Total reported value, excl. options
-
$52M
-
Value change
-
-$5.39M
-
Put/Call ratio
-
1.75
-
Number of buys
-
43
-
Number of sells
-
-46
-
Price
-
$1.82
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2025
125 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2025.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.6M shares
of 53M outstanding shares and own 53.89% of the company stock.
Largest 10 shareholders include CAS Investment Partners, LLC (5.61M shares), BlackRock, Inc. (3.15M shares), VANGUARD GROUP INC (2.67M shares), 683 Capital Management, LLC (1.55M shares), KPS Global Asset Management UK Ltd (1.22M shares), WORLDLY PARTNERS MANAGEMENT, LLC (1.16M shares), MIRABELLA FINANCIAL SERVICES LLP (1.16M shares), GEODE CAPITAL MANAGEMENT, LLC (1.12M shares), STATE STREET CORP (901K shares), and D. E. Shaw & Co., Inc. (862K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.